Anticoagulation control in hospitalised patients on warfarin

Su, EY; Naganathan, V; Fallah, H; Bajorek, BV; McLachlan, AJ

Anticoagulation control in hospitalised patients on warfarin

Su, EY Naganathan, V Fallah, H Bajorek, BV

McLachlan, AJ

Permalink

Publication Type:: Journal Article
Citation:: Journal of Pharmacy Practice and Research, 2008, 38 (4), pp. 292 - 295
Issue Date:: 2008-01-01

Closed Access

	Filename	Description	Size
	2010004367OK.pdf		418.78 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Su, EY	en_US
dc.contributor.author	Naganathan, V	en_US
dc.contributor.author	Fallah, H	en_US
dc.contributor.author	Bajorek, BV https://orcid.org/0000-0002-2532-7187	en_US
dc.contributor.author	McLachlan, AJ	en_US
dc.date.issued	2008-01-01	en_US
dc.identifier.citation	Journal of Pharmacy Practice and Research, 2008, 38 (4), pp. 292 - 295	en_US
dc.identifier.issn	1445-937X	en_US
dc.identifier.uri	http://hdl.handle.net/10453/17099
dc.description.abstract	Background: Anticoagulation control is a strong predictor of Iclinical outcomes for patients on warfarin. Aim: To identify instances of excessive anticoagulation in hospitalised patients on warfarin and to determine the causes of international normalised ratios (INRs) of 5 and above and the management strategies used to correct it. Method: An observational descriptive study undertaken at a teaching hospital over a 3-month period. Data were reviewed prospectively and retrospectively to measure the percentage of time patients were maintained within their target INR range while in hospital and to identify cases of excessive anticoagulation. Patients were divided into a control group (INR < 5) and a high INR group (INR ≥ 5). Possible causes of INRs of 5 and above and its management strategies were recorded. Results: Out of a total of 208 patients on warfarin identified in the geriatric, orthopaedic and cardiology wards, 144 patients met the study criteria. The mean percentage of time spent within, above and below the target INR range by the control group was 60%, 0% and 15%, and by the high INR group was 41%, 33% and 16%, respectively. In the high INR group, 26 possible causes of INRs of 5 and above were identified and the co-administration of roxithromycin and warfarin were implicated in 7 cases. Management strategies for INRs of 5 and above were compared between two stratified groups (INR 5-9 and INR ≥ 9). The management strategies adopted included warfarin dose reduction (83%; 86%), temporary withholding of warfarin (100%; 100%), administration of vitamin K (58%; 100%), fresh frozen plasma (13%; 43%) and prothrombin complex concentrate (8%; 29%). The time to return to the upper limit of the target INR range was INR 5-9 (1.6 SD 1.5 days) and INR ≥ 9 (0.5 SD 0.4 days). Conclusion: Anticoagulation control is difficult for hospital patients and drug interactions are an important contributing factor. The management strategies adopted to correct excessive anticoagulation followed the relevant guidelines.	en_US
dc.relation.ispartof	Journal of Pharmacy Practice and Research	en_US
dc.relation.isbasedon	10.1002/j.2055-2335.2008.tb00392.x	en_US
dc.subject.classification	Pharmacology & Pharmacy	en_US
dc.title	Anticoagulation control in hospitalised patients on warfarin	en_US
dc.type	Journal Article
utslib.citation.volume	4	en_US
utslib.citation.volume	38	en_US
utslib.for	1115 Pharmacology and Pharmaceutical Sciences	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Graduate School of Health
utslib.copyright.status	closed_access
pubs.issue	4	en_US
pubs.publication-status	Published	en_US
pubs.volume	38	en_US

Abstract:

Background: Anticoagulation control is a strong predictor of Iclinical outcomes for patients on warfarin. Aim: To identify instances of excessive anticoagulation in hospitalised patients on warfarin and to determine the causes of international normalised ratios (INRs) of 5 and above and the management strategies used to correct it. Method: An observational descriptive study undertaken at a teaching hospital over a 3-month period. Data were reviewed prospectively and retrospectively to measure the percentage of time patients were maintained within their target INR range while in hospital and to identify cases of excessive anticoagulation. Patients were divided into a control group (INR < 5) and a high INR group (INR ≥ 5). Possible causes of INRs of 5 and above and its management strategies were recorded. Results: Out of a total of 208 patients on warfarin identified in the geriatric, orthopaedic and cardiology wards, 144 patients met the study criteria. The mean percentage of time spent within, above and below the target INR range by the control group was 60%, 0% and 15%, and by the high INR group was 41%, 33% and 16%, respectively. In the high INR group, 26 possible causes of INRs of 5 and above were identified and the co-administration of roxithromycin and warfarin were implicated in 7 cases. Management strategies for INRs of 5 and above were compared between two stratified groups (INR 5-9 and INR ≥ 9). The management strategies adopted included warfarin dose reduction (83%; 86%), temporary withholding of warfarin (100%; 100%), administration of vitamin K (58%; 100%), fresh frozen plasma (13%; 43%) and prothrombin complex concentrate (8%; 29%). The time to return to the upper limit of the target INR range was INR 5-9 (1.6 SD 1.5 days) and INR ≥ 9 (0.5 SD 0.4 days). Conclusion: Anticoagulation control is difficult for hospital patients and drug interactions are an important contributing factor. The management strategies adopted to correct excessive anticoagulation followed the relevant guidelines.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/17099